ANTX
NASDAQ
$4.80
AN2 Therapeutics Inc (ANTX)
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9 (+87.50%)
Market Cap
$168M
Free Cash Flow Yield
-18.61%
Beta (5Y)
0.61
Price Chart
Valuation
Market Cap$168M
P/B2.10
Profitability
EBITDA-$35M
EPS-$1.17
Financial Health
Free Cash Flow Yield-18.61%
Growth & Risk
Beta (5Y)0.61
Sharpe Ratio1.61